Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.5 EUR
27.28 M EUR
175.30 M EUR
20.50 M
About LeMaitre Vascular, Inc.
Sector
Industry
CEO
George W. LeMaitre
Website
Headquarters
Burlington
Founded
1983
FIGI
BBG000RC73D5
LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange LEMAITRE VASCULAR DL -,01 stocks are traded under the ticker LHU.
We've gathered analysts' opinions on LEMAITRE VASCULAR DL -,01 future price: according to them, LHU price has a max estimate of 107.99 EUR and a min estimate of 78.46 EUR. Watch LHU chart and read a more detailed LEMAITRE VASCULAR DL -,01 stock forecast: see what analysts think of LEMAITRE VASCULAR DL -,01 and suggest that you do with its stocks.
Yes, you can track LEMAITRE VASCULAR DL -,01 financials in yearly and quarterly reports right on TradingView.
LEMAITRE VASCULAR DL -,01 is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
LHU earnings for the last quarter are 0.44 EUR per share, whereas the estimation was 0.39 EUR resulting in a 12.64% surprise. The estimated earnings for the next quarter are 0.47 EUR per share. See more details about LEMAITRE VASCULAR DL -,01 earnings.
LEMAITRE VASCULAR DL -,01 revenue for the last quarter amounts to 49.24 M EUR, despite the estimated figure of 48.05 M EUR. In the next quarter, revenue is expected to reach 53.45 M EUR.
LHU net income for the last quarter is 10.01 M EUR, while the quarter before that showed 11.04 M EUR of net income which accounts for −9.37% change. Track more LEMAITRE VASCULAR DL -,01 financial stats to get the full picture.
Yes, LHU dividends are paid quarterly. The last dividend per share was 0.15 EUR. As of today, Dividend Yield (TTM)% is 0.59%. Tracking LEMAITRE VASCULAR DL -,01 dividends might help you take more informed decisions.
LEMAITRE VASCULAR DL -,01 dividend yield was 0.99% in 2023, and payout ratio reached 41.71%. The year before the numbers were 1.09% and 53.72% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 23, 2024, the company has 630.00 employees. See our rating of the largest employees — is LEMAITRE VASCULAR DL -,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LEMAITRE VASCULAR DL -,01 EBITDA is 53.18 M EUR, and current EBITDA margin is 24.08%. See more stats in LEMAITRE VASCULAR DL -,01 financial statements.
Like other stocks, LHU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LEMAITRE VASCULAR DL -,01 stock right from TradingView charts — choose your broker and connect to your account.